6228-2276 Screening compound: N-(6-chloro-1,3-benzothiazol-2-yl)-3-[(4-chloro-1H-pyrazol-1-yl)methyl]benzamide

6228-2276 Screening compound: N-(6-chloro-1,3-benzothiazol-2-yl)-3-[(4-chloro-1H-pyrazol-1-yl)methyl]benzamide
6228-2276 Screening compound: N-(6-chloro-1,3-benzothiazol-2-yl)-3-[(4-chloro-1H-pyrazol-1-yl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 6228-2276
N-(6-chloro-1,3-benzothiazol-2-yl)-3-[(4-chloro-1H-pyrazol-1-yl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6228-2276

Molecular Formula

C18H12Cl2N4OS (C18 H12 Cl2 N4 OS)

Compound Name

N-(6-chloro-1,3-benzothiazol-2-yl)-3-[(4-chloro-1H-pyrazol-1-yl)methyl]benzamide

IUPAC name

N-(6-chloro-13-benzothiazol-2-yl)-3-[(4-chloro-1H-pyrazol-1-yl)methyl]benzamide

SMILES

O=C(c1cc(Cn2ncc(Cl)c2)ccc1)Nc1nc(ccc(Cl)c2)c2s1

InChI

InChI=1S/C18H12Cl2N4OS/c19-13-4-5-15-16(7-13)26-18(22-15)23-17(25)12-3-1-2-11(6-12)9-24-10-14(20)8-21-24/h1-8,10H,9H2,(H,22,23,25)

InChI Key

MFSTZLDECZVFLF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02372095

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

403.29

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.796

Distribution Coefficient, logD

4.749

Water Solubility, LogSw

-5.01

Polar Surface Area

47.597

Acid Dissociation Constant (pKa)

8.34

Base Dissociation Constant (pKb)

-0.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.60

6228-2276 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Nucleic Acid Ligands (8311 compounds)

Anti-HIV1 Library (19540 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with 6228-2276 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6228-2276?
Check Price and Availability of 6228-2276, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6228-2276 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6228-2276
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6228-2276
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6228-2276 available by request